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Checkpoints that limit stem cell self-renewal in
response to DNA damage can contribute to cancer
protection but may also promote tissue aging.
Molecular components that control stem cell
responses to DNA damage remain to be delineated.
Using in vivo RNAi screens, we identified basic
leucine zipper transcription factor, ATF-like (BATF)
as a major component limiting self-renewal of
hematopoietic stem cells (HSCs) in response to
telomere dysfunction and g-irradiation. DNA damage
induces BATF in a G-CSF/STAT3-dependent
manner resulting in lymphoid differentiation of
HSCs. BATF deletion improves HSC self-renewal
and function in response to g-irradiation or telomere
shortening but results in accumulation of DNA
damage in HSCs. Analysis of bone marrow from
patients with myelodysplastic syndrome supports
the conclusion that DNA damage-dependent in-
duction of BATF is conserved in human HSCs.
Together, these results provide experimental evi-
dence that a BATF-dependent differentiation check-
point limits self-renewal of HSCs in response to DNA
damage.INTRODUCTION
An age-dependent decline in stem cell function occurs in various
tissues and this decline contributes to impairments in tissue
homeostasis during aging (Rando 2006, Sharpless and DePinho
2007). On the molecular level, there is experimental evidence
that the accumulation of DNA damage can accelerate aging in
mouse models and human progeria syndromes (Rudolph et al.,
1999, Hoeijmakers 2009, Sahin and DePinho 2010). An age-
dependent accumulation of DNA damage occurs in tissue
stem cells (Rossi et al., 2007, Ru¨be et al., 2011). DNA damage
checkpoints that limit the function of aging stem cells remain
to be delineated.
Unbiased, functional genomic approaches can be conducted
at stem cell level (Hope et al., 2010) and studies on carcinogen-
esis demonstrated the power of such approaches to discover
tumor suppressor checkpoints (Zender et al., 2008). Tumor
suppressor checkpoints can also limit the regenerative capacity
of tissues during aging, e.g., p53, p16, p21 (Chin et al., 1999,
Signer et al., 2008, Janzen et al., 2006, Liu et al., 2011, Molofsky
et al., 2006, Nishino et al., 2008, Choudhury et al., 2007, Sharp-
less and DePinho 2007). This dual role of checkpoint genes in
cancer protection and aging could also be relevant at stem cell
level (Pelicci 2004, Beausejour and Campisi 2006, Sharpless
and DePinho 2007). It is possible that DNA damage checkpoints
protect from stem cell-derived cancer but contribute to impair-
ments in stem cell function during aging.Cell 148, 1001–1014, March 2, 2012 ª2012 Elsevier Inc. 1001
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Figure 1. In Vivo RNAi Screening Identifies Candidate Checkpoints in Telomere Dysfunctional HSCs
(A–C) Freshly isolated KSL cells from 3 month old mTerc+/+ and G3 mTerc/ mice (n = 24 mice per group) were infected with a pool of lentiviruses and were
transplanted for 2 rounds into lethally irradiated recipients (n = 24 mice per group) along with noninfected KSL cells from the same culture. Four weeks later,
Lin- BM cells were analyzed by deep sequencing.
(B) The histogram depicts the numbers of shRNAs that were detected by deep sequencing in virus producer cells and Lin- bone marrow cells from secondary
recipients.
(C) Histogram showing the strongest selected shRNAs in G3 mTerc/ Lin- cells compared to mTerc+/+ Lin- cells.
(D–H) Freshly isolated KSL cells from mTerc+/+ or G3 mTerc/ mice (n = 8 donors per group) were infected with single shRNA constructs targeting
candidate genes or with a scrambled shRNA control. The infection rate was 22%–50% and was normalized to 1. Infected cells were transplanted into
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Telomere shortening represents a cell intrinsic mechanism
contributing to the accumulation of DNA damage in aging cells
(d’Adda di Fagagna et al., 2003). Critically short telomeres lose
capping function at chromosome ends and induce DNA damage
responses (Chin et al., 1999, d’Adda di Fagagna et al., 2003) that
lead to induction of cell cycle arrest or apoptosis (Lee et al., 1998,
Wright and Shay, 1992). Studies on late generation telomerase
knockout mice revealed experimental evidence that telomere
dysfunction impairs somatic stem cell maintenance and function
(Wong et al., 2003; Allsopp et al., 2003) by induction of DNA
damage checkpoints (Choudhury et al., 2007, Schaetzlein
et al., 2007).
Hematopoietic stem cells (HSCs) represent one of the best-
studied somatic stem cell systems. HSC aging is characterized
by a decline in the repopulation capacity and skewed differenti-
ation (Morrison et al., 1996, Sudo et al., 2000, Rossi et al., 2005)
likely contributing to the age-associated defects in immune func-
tions (Wang et al., 2011, Rossi et al., 2008, Linton and Dorshkind
2004). Themolecular pathways that impair repopulation capacity
and differentiation of aging HSCs are largely unknown.
Here, we conducted a small in vivo RNAi screen to identify
molecular pathways inhibiting HSC function in response to telo-
mere dysfunction. The study provides experimental evidence for
a differentiation checkpoint limiting self-renewal of HSCs in
response to DNA damage. This checkpoint appears to be
conserved in human HSCs and could represent a major target
to prevent functional decline and the evolution of malignancies
in the aging hematopoietic system.
RESULTS
In Vivo RNAi Screening Identifies Target Genes
Rescuing the Repopulation Capacity of Telomere
Dysfunctional Stem Cells
An in vivo RNAi screen was conducted on transplanted HSCs
from telomere dysfunctional mice (third generation telomerase
knockout: G3 mTerc/) compared to wild-type mice with long
telomere reserves (mTerc+/+, n = 24donors per group, Figure 1A).
The RNAi library was derived from a recently published set of
shRNAs targeting 947 cancer related genes (Bric et al., 2009,
Figure S1, Table S1). cKit+ Sca1+ lineage- (KSL) cells from the
donor cohorts were pooled and infected with the shRNA pool
(multiplicity of infection: 10–30, transduction efficiency: 82%–
84%). On average, each shRNA was infected in approximately
500 KSL cells. Virally transduced KSL cells were transplanted
for two consecutive rounds into lethally irradiated recipients.
Four weeks later, hematopoietic cells were isolated and deep
sequencing revealed that the vast majority of shRNAs were still
present in hematopoietic cells (Figure 1B) indicating that imbal-
ances in the prevalence of individual shRNAs did not occur
because of the random loss of shRNAs.
Seven shRNAs were strongly selected in recipients trans-
planted with G3 mTerc/ HSCs compared to recipients oflethally irradiated recipients along with noninfected cells from the same cul
peripheral blood chimerism of infected cells (GFP-positive) in primary recipie
mean ± SEM.
See Figure S1 and Table S1, Table S2, Table S3, and Table S4.mTerc+/+ HSCs (Figure 1C, Table S2). Single construct experi-
ments showed that 4 out of 7 candidate shRNAs were positively
selected in transplanted G3mTerc/HSCs (Figures 1D–1G). All
of these shRNAs exhibited a good knockdown efficiency of
target genes on mRNA level (Figure S1B, Table S3). Three of
the shRNAs also showed a positive selection in primary recipi-
ents transplanted with mTerc+/+ hematopoietic cells albeit less
pronounced compared to G3 mTerc/ HSCs (Figures 1E–1G).
The strongest selected shRNAs inG3mTerc/ hematopoietic
cells (497-fold enriched compared to mTerc+/+ hematopoietic
cells) targeted the ‘‘Basic leucine zipper transcription factor,
ATF-like,’’ also known as Batf (Dorsey et al., 1995, Figure 1C).
Two independent shRNAs targeting Batf had no measurable
effect on mTerc+/+ hematopoietic cells but were strongly
selected in transplanted G3mTerc/ hematopoietic cells corre-
lating with knockdown efficiency of the 2 shRNAs (Figure S1B,
Figure 1D). Previous studies showed that p21 deletion rescues
the function of telomere dysfunctional HSCs (Choudhury et al.,
2007). shRNA mediated knockdown of p21 shRNA was similarly
effective in rescuing the repopulation capacity of telomere
dysfunctional KSL cells compared to Batf knockdown (Figures
1D and 1H). Among other shRNAs in the RNAi library that tar-
geted DNA damage checkpoint genes (Atm, Gadd45a and
Gadd45 g, Caspase 3, Rad17, a.o.), the Batf shRNA was most
strongest selected in hematopoietic cells from G3 mTerc/
mice compared to mTerc+/+ mice (Table S4).
BatfDeletion Improves Self-Renewal but Increases DNA
Damage Accumulation of HSCs in Response to
Telomere Dysfunction or g-Irradiation
Chimeric bone marrow (BM) from primary recipients that were
transplanted with shRNA Batf infected along with noninfected
KSL cells (Figure 1D) was serially transplanted into secondary
and tertiary recipients. Batf knockdown was not selected in seri-
ally transplanted mTerc+/+ BM, but exhibited a strong, positive
selection in serially transplanted G3 mTerc/ BM (Figure 2A).
Purified Batf shRNA infected G3 mTerc/ BM cells (5x
106 GFP+ cells) rescued lethally irradiated tertiary recipients,
whereas vector control infected BM cells from the same donors
exhausted at this stage (Figure 2B). These results indicated that
Batf knockdown improved self-renewal of G3mTerc/HSCs. In
line with this interpretation, shRNA mediated knockdown of
Batf rescued HSC numbers in long-term engrafted primary
(Figure 2C) and secondary recipients of G3 mTerc/ hemato-
poietic cells (data not shown). Control experiments confirmed
that HSC self-renewal was compromised in aging G3 mTerc/
mice but not in G1 mTerc/ mice indicating that telomere
shortening rather than mTerc gene status by itself limited HSC
self-renewal (Figure S2A). Competitive transplantation of 200
or 400 highly purified shRNA infected HSCs (CD34-KSL) from
primary recipients confirmed that Batf knockdown improved
multilineage repopulation capacity of G3 mTerc/ HSCs (Fig-
ure 2D, Figure S2B). Telomere length analysis by quantitativeture (n = 3 recipients for each group). The histograms depict changes in
nts at the indicated time points after transplantation. Values are shown as
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Figure 2. Batf Deletion Improves Self-Renewal but Increases DNA Damage Accumulation of HSCs in Response to Telomere Dysfunction or
g-Irradiation
(A–E) Batf shRNA and scrambled shRNA infected KSL cells of G3 mTerc/ and mTerc+/+ mice were transplanted into lethally irradiated recipients along with
noninfected KSL cells. shRNA expressing lentiviruses coexpressed GFP. (A) Bone marrow (BM) of primary recipients was serially transplanted. The histogram
shows changes in peripheral blood chimerism, 1 month after transplantation at the indicated round of serial transplantation. (B) In the 3rd round of serial
transplantation 53 106 purified, infected BM cells were transplanted into lethally irradiated mice. The Kaplan Meier histogram depicts survival rates of recipients
of Batf shRNA or scrambled shRNA infected G3mTerc/ bone marrow cells (n = 3 mice per group). (C) The histogram shows the numbers of HSCs (CD34-KSL
cells) in GFP+ BM cells of long-term engrafted (4 months after transplantation), primary recipients (n = 5mice per group). (D) Purified HSCs (200 or 400 CD34-KSL
cells) from primary recipients were transplanted into lethally irradiated recipients together with 500,000 competitor cells (total BM). The histogram shows the
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fluorescence in situ hybridization (qFISH) showed that Batf defi-
ciency prolongedmaintenance of HSCwith shortened telomeres
(Figure 2E).
Bone marrow cells of Batf knockout mice (Batf/) and wild-
type mice (Batf+/+) were transplanted into lethally irradiated
recipients along with Batf+/+ competitor cells. When primary
recipients were exposed to a single dose of 4 Gy g-irradiation,
Batf/ HSCs were positively selected (Figures 2F and 2G).
Immunofluorescence staining against gH2AX (a marker of DNA
breaks) indicated that Batf deficiency prolonged maintenance
of HSCs carrying DNA damage (Figure 2H).
Together, these data indicated that Batf deletion or knock-
down can improve the maintenance and function of HSCs in
the context of telomere dysfunction or g-irradiation but this
rescue results in an accumulation of DNA damage and
telomere shortening in the HSC pool. This conclusion was
further supported by an analysis of the effects of Batf knock-
down on hematopoietic progenitor cells. Specifically, shRNA-
mediated knockdown of Batf rescued the impaired capacity of
G3 mTerc/ HSCs to generate multipotent progenitor cells
(MPPs, p = 0.001, Figure S2C and S2F) and common myeloid
progenitors (CMPs, p = 0.007, Figures S2D and S2F). Batf
knockdown had minor effects on the generation of MPPs or
CMPs in mTerc+/+ HSC recipients (Figures S2C, S2D, and
S2F). Batf-knockdown reduced the number of common
lymphoid progenitors (CLPs) in recipients of both mTerc+/+ and
G3 mTerc/ HSCs (Figures S2E and S2F). These data sug-
gested that Batf could contribute to early stages of lymphoid
lineage differentiation of HSCs. An alternative explanation indi-
cated that Batf was required for survival of CLPs. In agreement
with this interpretation, ex vivo infection of freshly purified
CLPs from wild-type mice revealed that Batf knockdown
impaired the survival of cultured CLPs (Figure S3A). Along with
these data on impaired CLP formation/maintenance, recipients
of Batf shRNA-infected HSCs exhibited a skewing in HSC
differentiation resulting in increased myelopoiesis and
decreased lymphopoiesis compared to recipients of scrambled
shRNA infected HSCs (Figures S3B–S3D). Transplantation of
Batf shRNA versus scrambled shRNA targeted CMPs showed
that Batf knockdown did not induce self-renewal of CMPs (n =
5 mice per group, Figure S3E). These data support the conclu-
sion that Batf knockdown rescued the repopulation capacity of
G3 mTerc/ HSCs rather than self-renewal of CMPs.
Batf Upregulation Impairs HSC Function in Response
to Aging and DNA Damage
mRNA annalysis of freshly purified HSCs and hematopoietic
progenitor cells from 3- and 12-month-old mice revealed that
Batf mRNA expression was upregulated in hematopoieticpercentage of test donor-derived bone marrow cells 3 months after transplantat
purifiedHSCs (CD34-KSL cells) from secondary recipients, 12weeks after transpla
(TFI) over all analyzed nuclei. Lines depict mean values.
(F–H) Total BM of Batf/ mice (CD45.2) was transplanted into 20 lethally irradiat
transplantation, 10 recipients were g-irradiated with 4Gy, 10 remained nonirrad
histogram depicts changes in the percentage of Batf-/- CD34-KSL cell (CD45.2) in
flow cytometry. (H) The histogram depicts the percentage of purified HSCs (CD
rescence staining. The dotted line represents the mean value. (A,C,D,E) Values a
See Extended Experimental Procedures and Figure S2 and Figure S3.progenitor cells (Figure 3A) as well as in long-term HSCs (Fig-
ure 3B) of G3 mTerc/ mice compared to mTerc+/+ mice. In
both cohorts, an age-dependent induction of Batf mRNA levels
was observed in HSCs (Figure 3B) possibly reflecting the
increasing levels of DNA damage in aging HSCs (Rossi et al.,
2007). On protein level, increased expression of BATF was
seen in hematopoietic progenitor cells (KSL) and HSCs
(CD34-KSL) of G3 mTerc/ mice compared to mTerc+/+ mice
(Figures 3C and 3D). Again, there was an age-dependent
increase in both cohorts (Figure 3C).
Batf mRNA expression was also measured in freshly isolated
HSCs from mTerc+/+ mice at different time points after 4 Gy
whole body g-irradiation (IR). There was a significant induction
of Batf mRNA expression from 6-48 hr after IR (Figure 3E,
n = 3 mice per group). Irradiation-induced BATF expression
was confirmed on protein level in freshly isolated HSCs (Fig-
ure 3F). Batf–cDNA expression experiments demonstrated that
overexpression of Batf limited the repopulation capacity of
HSCs (Figure S4A, Figure 3G,H).
G-CSF/STAT3-Dependent but p53-Independent
Upregulation of BATF in HSCs in Response
to DNA Damage
An analysis of BATF protein expression in freshly isolated Lin-
cells of g-irradiated (4Gy) and nonirradiated Trp53 knockout
mice (Trp53/) revealed that DNA damage-induced expression
of BATFwas p53-independent (Figure 4A). Previous studies sug-
gested that STAT3-dependent upregulation of BATF induces
differentiation of murine leukemia cells (Senga et al., 2002) and
G-CSF can activate STAT3 (Tian et al., 1994). An analysis of
BATF protein expression in Lin- cells of nonirradiated and
irradiated G-Csf knockout mice (G-Csf/) and control mice
(G-Csf+/) revealed that the induction of BATF in response
to g-irradiation was G-CSF-dependent (Figure 4B). Cell
culture experiments showed that stimulation with G-CSF-
induced BATF protein levels in freshly isolated hematopoietic
cells (Lin-) from wild-type mice and this induction was strongly
STAT3-dependent (Figure 4C, Figure S4B). Transplantation
of shRNA-transduced G3 mTerc/ KSL cells showed that
Stat3 knockdown rescued the repopulation capacity of G3
mTerc/ KSL cells (Figure 4D, p < 0.001). Together, these
experiments indicated that STAT3/G-CSF-dependent upregula-
tion of BATF impairs the self-renewal of HSCs in response to
DNA damage.
DNA Damage Induces BATF-Dependent Lymphoid
Differentiation of HSCs
BATF was implicated in the differentiation of peripheral lympho-
cytes (Betz et al., 2010, Schraml et al., 2009). Here, the mRNAion (n = 5 recipients per group). (E) Telomere length was analyzed by qFISH in
ntation. The dot blot shows the distribution of telomere fluorescence intensities
ed recipients together with Batf+/+ competitor cells (CD45.1). One month after
iated. Bone marrow of recipient mice was analyzed 2 months later. (F) The
nonirradiate (NIR) versus irradiate (IR) recipients. (G) Representative blots from
34-KSL) showing the indicated number of gH2AX foci per cell in immunofluo-
re shown as mean ± SEM.
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Figure 3. Batf Upregulation Impairs HSC Function in Response to Aging and DNA Damage
(A and B) The histograms show the mRNA expression of Batf relative to Gapdh in freshly purified progenitor cells from 3 and 12 month old mTerc+/+ and G3
mTerc/mice in: (A) short-term hematopoietic stem cells (ST-HSCs: CD34+Flt3- KSL), multipotent progenitor cells (MPPs: CD34+, Flt3+, KSL), commonmyeloid
progenitor cells (CMPs: Lin-, Sca-1-, c-Kit+, CD34+, CD16/32lo), and common lymphoid progenitor cells (CLPs: Lin-, Sca-1lo, c-Kitlo, IL7R+, Flt3+); (B) long-term
HSCs (CD34- Flt3- KSL), (n = 3 mice per group; data are shown as mean; error bar represent SEM).
(C) Representative Western blot showing expression of BATF in freshly isolated hematopoietic progenitor cells (KSL) of 3 and 10-12 month old G3mTerc/ and
mTerc+/+ mice (n = 3 mice per group).
1006 Cell 148, 1001–1014, March 2, 2012 ª2012 Elsevier Inc.
expression of lymphoid and myeloid marker genes that carry
putative AP1-binding sides in the promoters, was measured in
purified HSCs from 10-12 month oldmTerc+/+ and G3mTerc/
mice (Figures 5A–5C, Table S5). Telomere dysfunction and
g-irradiation was associated with a significant induction of
genes associated with lymphoid differentiation and an inhibition
of genes associated with myeloid differentiation (Figures 5A–5C,
n = 3 mice per group). Freshly isolated G3mTerc/ HSCs were
transduced with Batf shRNA or scrambled shRNA. Targeted
HSCswere transplanted into wild-type recipients and re-isolated
4 months after transplantation. qPCR showed that the knock-
down of Batf reverted the induction of lymphoid differentiation
in G3 mTerc/ HSCs (Figure 5C).
Interleukin-7-receptor (IL7R) knockin mice express Cre-
recombinase under the endogenous IL7R promoter. When
crossed to Cre-inducible reporter mice (e.g., Rosa26-lox-stop-
lox-YFP), activation of the IL7R marks the onset of lymphoid
differentiation by inducing reporter gene expression. It was
shown that IL7R-reporter gene is not expressed at HSC level
but gets activated during lymphoid differentiation at CLP level
(Schlenner et al., 2010). Here, a significant induction of IL7R-
reporter activity was detected 12 hr after 4Gy g-irradiation in
HSCs (CD34-KSL) compared to nonirradiated mice (Figure S4C).
The CD150 marker (Kiel et al., 2005) can subdivide CD34-KSL
cells into myeloid competent HSCs (expressing high levels of
CD150 = CD150hi) and lymphoid competent HSCs (expressing
low levels of CD150 = CD150lo, Morita et al., 2010, Beerman
et al., 2010). CD150-negative CD34-KSL cells were not included
in our analysis since these cells may not represent true stem
cells (Kiel et al., 2008). Analyzing HSCs in response to g-irradia-
tion revealed a significant induction of IL7R-reporter activity in
CD150lo HSCs and to a much smaller extend in CD150hi HSCs
(Figures 5D and 5E) suggesting that lymphoid competent
HSCs were more sensitive to DNA damage-induced lymphoid
differentiation.
CD150hi and CD150lo HSCs of irradiated donor mice were
separated according to the induction of IL7R-reporter and re-
transplanted into lethally irradiated mice along with competitor
cells. Il7R-reporter negative HSCs maintained some long-
term, multilineage engraftment capacity, whereas IL7R-positive
HSCs had lost this capacity (Figure S4D). Multilineage analysis
revealed that IL7R+ HSCs differentiated into lymphoid cells
(Figures S4E and S4F). Together, these data indicated that
irradiation induces lymphoid differentiation thereby limiting
the functional capacity of HSCs. Irradiation of long-term recipi-
ents of Batf shRNA or scrambled shRNA infected KSL cells(D) Representative Western blot showing expression of BATF in freshly isolated
mTerc+/+ mice (n = 5 mice per group).
(E) The histogram shows the mRNA expression of Batf relative to Gapdh in freshly
the indicated time points after g-irradiation (4 Gy, n = 3 mice per time point).
(F) Representative Western blot showing expression of Batf in freshly isolated h
mTerc+/+ mice with or without g-irradiation (4Gy, 12 hr after IR, n = 5 mice per g
(G) Representative Western blot showing expression of BATF in freshly isolate
scrambled shRNA transduced KSL cells from mTerc+/+ mice.
(H) Batf-cDNA or empty vector infected KSL cells were transplanted along with n
40%–50% and was normalized to 1. The histogram depicts changes in periphera
indicated time points after transplantation (n = 3 recipients per group; data are s
See Figure S4A.from IL7R-reporter mice revealed that DNA damage-induced
lymphoid differentiation of CD150lo HSCs was BATF-dependent
(Figures 5D and 5F).
IL7R-reporter induction was also analyzed ex vivo in freshly
isolated, highly purified HSCs that were cocultured on OP9
feeder cells to foster lymphoid differentiation if present. Irradia-
tion-induced lymphoid differentiation in 13.7 ± 1.21% of
CD150hi HSCs (Figures 5G and 5H) and in 52% of CD150lo
HSCs (Figure 5I). Since the percentage of contaminating
lymphoid competent progenitor was significantly lower in both
HSC compartments (0% in CD150hi HSCs, 28% in CD150lo
HSC, Figure S4G). Specifically, recent studies revealed that
35%–45% of CD34-KSL cells represent ‘true stem cells’ exhib-
iting long-term, multilineage engraftment in single cell transplan-
tation assays (Morita et al., 2010). However, this assay likely
underestimates the percentage of ‘true stem cells’, since the
seeding efficiency in single cell transplantation experiments is
limited and only 50%–80% of the transplanted cells engraft.
Here, we analyzed the cellular composition of myeloid compe-
tent HSCs (CD150hiCD34-KSL cells) that engraft in single cell
transplantation assay. This population contains 68% ‘true
HSCs’ (showing long-term multilineage engraftment) and 32%
myeloid-restricted progenitor cells (showing only transient,
myeloid-restricted engraftment) but no lymphoid competent
progenitor cells (Figure S4G). The population of lymphoid
competent HSCs (CD150loCD34-KSL cells) that engraft in
single cell transplantation assays contains 43% ‘true HSCS’
(showing long-term, multilineage engraftment), 28.5% of multi-
potent progenitor cells (MPPs, showing transient multilineage
engraftment) and 28.5% myeloid-restricted progenitor cells
(showing transient,myeloid-restricted engraftment) (FigureS4G).
Control experiments verified that irradiation does not induce
lymphoid differentiation of myeloid-restricted progenitor cells
(Figure S4H). Together, these data demonstrated that irradia-
tion-induced lymphoid differentiation affected ‘true HSC’ within
both HSC populations.
Isolation of HSCs from recipients that were transplanted with
shRNA infected HSCs revealed that Batf knockdown completely
prevented DNA damage-induced activation of IL7R-reporter
in freshly isolated CD150lo HSCs under ex vivo culture condi-
tions (Figures 5J and JK). A series of control experiments
excluded that significant numbers of HSCs changed surface
markers or that significant numbers of lymphoid progenitor cells
moved into the population of surface marker defined HSCs
at the investigated time points after DNA damage induction
(Figure S5).HSCs (CD34-KSL) from bone marrow of 10-12 month old G3 mTerc/ and
isolated HSCs (CD34-KSL) from bone marrow of 3 month oldmTerc+/+mice at
ematopoietic stem cells (CD34- KSL) from bone marrow of 10-12 month old
roup).
d, Lin- BM cells, 5 weeks after transplantation of shRNA-Batf, cDNA-Batf or
oninfected cells into lethally irradiated recipients. The infection efficiency was
l blood chimerisms of infected cells (GFP-positive) in primary recipients at the
hown as mean ± SEM).
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Figure 4. G-CSF/STAT3-Dependent Induction of BATF Limits the
Repopulation Capacity of HSCs in Response to DNA Damage
(A–C) Representative Western blots showing the expression of BATF (A) in
freshly isolated Lin- cells from irradiated (4 Gy, 6 hr after irradiation) and
nonirradiated Trp53/ mice (n = 2 mice per group), (B) in freshly isolated Lin-
cells from irradiated (4 Gy, 6 hr after irradiation) and nonirradiated G-Csf/
mice andG-Csf+/mice (n = 3mice per group), (C) in Lin- cells from donor mice
that were transplanted with Stat3 shRNA or a scrambled shRNA infected KSL
cells (10 weeks after Tx). Freshly isolated, GFP positive, Lin- cells were purified
and exposed for 3 days to G-CSF (10 ng/ml) or vehicle control (n = 2 repeat
experiments).
(D) Freshly isolated KSL cells frommTerc+/+ or G3mTerc/mice (n = 3 donors
per group) were infected with a Stat3-shRNA or a scrambled shRNA. The
infection rate was 24%–35% and was normalized to 1. Infected cells were
transplanted into lethally irradiated recipients alongwith noninfected cells from
the same culture (n = 3 recipients for each group). The histogram depicts
changes in peripheral blood chimerism of infected cells (GFP-positive) in
primary recipients at the indicated time point after transplantation. Values are
shown as mean ± SEM, n = 3 mice per group.
See Figure S4A.
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of Myeloid and Lymphoid Competent HSCs in Response
to Irradiation
The above data indicated that lymphoid competent (CD150lo)
HSCs were more sensitive to DNA damage-induced differentia-
tion than myeloid competent HSCs (CD150hi). However, an anal-
ysis of absolute HSC numbers at different time points after g-irra-
diation revealed that the number of CD150hi HSCs was also
reducedwithin24hrafter 4Gyg-irradiationalbeit lesspronounced
compared toCD150loHSCs (Figure 6A). At these early timepoints
after g-irradiation, there was only a slight induction of apoptosis
(5%–10%) and proliferation rates remained almost unchanged
in both CD150hi and CD150lo HSCs (Figures S6A and S6B) sug-
gesting that other factors were involved in the observed changes
in HSC numbers in response to IR. Previous studies on single cell
transplantations suggested that CD150hi HSCs can differentiate
into CD150lo HSCs (Morita et al., 2010). It was possible that this
differentiation process was induced by DNA damage in response
to IR. In agreement with this interpretation, we observed a tran-
sient increase in the number CD150lo HSCs from 6 to 12 hr after
g-irradiation paralleling the reduction in the total number of
CD150hi HSCs (Figure 6A). Mathematical modeling revealed an
improvement of model fitness for the observed kinetics of g-irra-
diation-induced changes in HSCnumberswhen (1) differentiation
ofCD150hi toCD150loHSCsand (2)depletionofCD150loHSCsby
lymphoid differentiation were included into the equation (Fig-
ure 6B, Extended Experimental Procedures, Figures S6C–S6I).
Plain models that were solely based on the rates of HSC prolifer-
ation (Figure S6A) and apoptosis (Figure S6B), exhibited signifi-
cantly higher error values as they were fitted to the observed
data (Figures 6C and 6D). To experimentally test this prediction,
highly purified CD150hi HSCs were transplanted into lethally irra-
diated recipient. 24 hr after transplantation, one half of the recip-
ients were g-irradiated (4 Gy), while the others remained nonirra-
diated (n = 4 mice per group). Analysis of donor-derived HSCs
(24 hr after IR) confirmed that irradiation-induced the transition
of CD150hi into CD150lo HSCs (Figure S6J). Mathematical
modeling also supported the experimental data indicating
that irradiation-induced lymphoid differentiation of ‘true HSCs’
within the populations of CD150hi and CD150lo HSCs (Figure 5,
Extended Experimental Procedures, Figures S7A–S7E).
mRNA expression of Batf was significantly induced in freshly
isolated HSCs of g-irradiated mice (12 hr after IR) in both
CD150hi and CD150lo HSCs (Figure S7F, n = 3 mice per group).
To test the functional role of DNA damage-dependent BATF
induction for the depletion of HSC subpopulations, g-irradiation
was applied (1) to Batf/ and Batf+/+ mice, (2) to mice that were
long-term reconstituted with Batf shRNA or scrambled shRNA
infected HSCs, and (3) to G-Csf/ and G-Csf+/ mice. The
depletion of CD150lo HSCs and CD150hi HSCs was significantly
rescued in all 3 scenarios, whileBatf orG-Csf gene status did not
affect the number of CD150lo or CD150hi HSCs in nonirradiated
recipients (Figures 6E–6G).
BATF Induction Contributes to Activation of DNA
Damage Signals in HSCs
Restrictions in self-renewal and induction of differentiation of
stem cells are associated with an activation of p53 and cell cycle
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inhibitors (e.g., p21, p16) (Kastan et al., 1991, Topley et al., 1999,
Akala et al., 2008, Choudhury et al., 2007). Here, p16 and p21
mRNA expression and p53 phosphorylation were analyzed in
long-term engrafted mice (4 month) that were transplanted
with Batf-shRNA versus scrambled-shRNA infected G3
mTerc/ HSCs. This analysis revealed that the induction of
p16, p21, and p53 phosphorylation in G3 mTerc/ hematopoi-
etic cells were Batf-dependent (Figures 7A–7D).
Activation of BATF in Human HSCs Correlates with
Telomere Shortening and Activation of DNA Damage
Signals
Myelodysplastic syndromes (MDS) are aging associated diseases
of the hematopoietic system leading to bone marrow failure,
skewed hematopoiesis, and a sharply increased risk of leukemia
formation.MDSarecharacterizedby increases inHSCproliferation
and telomere shortening (Ohyashiki et al., 1994). Here, the expres-
sion of Batf and p21mRNA and telomere length were analyzed in
freshly isolated CD34+ HSCs from bone marrow aspirates of
MDS patients. Telomere shortening associated with increased
p21 mRNA expression indicating that telomere shortening led to
anactivationofDNAdamagesignals (Figure7E). Therewasadirect
association of BATF expression levels with p21 expression (p =
0.005) and an inverse association of BATF expression with telo-
mere length (p < 0.001, Figures 7F and 7G). These data support
the view that increases in BATF expression represent a conserved
response to DNA damage in murine and human HSCs.
DISCUSSION
The current study provides experimental evidence for a differenti-
ation checkpoint limiting self-renewal of HSCs in response to
DNA damage. Melanocytic stem cells were previously shown to
differentiate in response to g-irradiation (Inomata et al., 2009).
Our new data support the hypothesis that differentiation may
represent ageneral responseof tissue stemcells toDNAdamage.
The current study identified amolecular pathway controlling stemFigure 5. DNA Damage Induces Lymphoid Differentiation of Hematopo
(A–C) The histograms show fold changes in the mRNA expression of lymphopo
(CD34-KSL) from 8-10 month old G3 mTerc/ versus mTerc+/+ mice, (B) HSCs (
Gy, 12 hr after IR), (C) GFP+ HSCs (CD34-KSL) from recipient mice, 16 weeks aft
from G3mTerc/mice. Fold changes of the transcriptional signatures are shown
a 0. The 2-sided Wilcoxon test was used to test the Null hypothesis of the fold c
(D–F)Micewere transplantedwith totalbonemarrow from Il7R- reportermiceorwith
were g-irradiated with 4 Gy (IR) or remained nonirradiated (NIR) (n = 3-4 mice per
analyzed in freshly isolatedCD150hi orCD150loHSCs. (D)Thehistogramshowsthe
and in lymphoidcompetentHSCs (CD150lo). (E)RepresentativeFACSanalysisof IL
indicate CD34-KSL cells, gates in right panel show IL7R-reporter positive cells in C
blotsshowing inductionof IL7R-reporter activity inCD150loHSCs isolated fromreci
cells from Il7R- reporter mice. Note that the induction of IL7R activity is impaired
scrambled shRNA infected HSCs (GFP+, upper gate in upper panel). IR induces Il
(G–I) Freshly isolated myeloid competent HSCs (CD150hiCD34-KSL cells) or lymp
cells. The induction of IL7R-activity wasmeasured in response to girradiation (4G
mean ±SD), (G) The histogram shows the percentage of IL7R-positive cells in CD1
show the induction of IL7R-activity in CD150hiCD34-KSL cells, 24 hr after IR ve
CD150loCD34-KSL cells, 12 and 24 hr after IR versus non-IR. Values are shown
(J and K) CD150lo HSCs were freshly isolated from recipients reconstituted with
1500 freshly purified CD150lo HSCs were sorted per well (n = 5 wells per group) a
12h later. (J) The histogram shows the induction of Il7R-reporter activity. Values ar
See Figure S4, Figure S5, and Table S5.
1010 Cell 148, 1001–1014, March 2, 2012 ª2012 Elsevier Inc.cell differentiation in response to DNA damage. Of note, this
checkpoint depends on BATF - a transcription factor known to
control lymphocyte differentiation in the hematopoietic system
(Betz et al., 2010, Schraml et al., 2009). It is tempting to speculate
that genotoxic stress enhances tissue specific differentiation
pathways in stem cells as a default response to DNA damage.
Stem Cell Differentiation Checkpoints: Implication
for Cancer Protection?
This study shows that abrogation of G-CSF/STAT3/BATF-
dependent differentiation prolongs self-renewal of HSCs in the
context of DNA damage but this rescue results in DNA damage
accumulation in stem cells. These data indicate that differentia-
tion represents an additional checkpoint layer to prevent survival
of damaged stem cells possibly protecting from stem cell-
derived cancers. The extreme quiescence of HSCs may have
selected for this additional checkpoint. Recent studies showed
that HSCs enter the cell cycle only once every 3–4 months (Wil-
son et al., 2008). It is conceivable that cell cycle arrest cannot
prevent aberrant DNA repair, which is known to occur in quies-
cent HSCs (Mohrin et al., 2010). Since quiescent cells are also
more resistant to DNA damage-induced cell death (Sullivan
et al., 1987), it is possible that apoptosis can also fail to prevent
the survival of quiescent HSCs harboring DNA damage.
Together, the induction of differentiation may thus represent
a critical failsafe mechanism eliminating quiescent stem cells
that accumulate genotoxic damage.
Stem Cell Differentiation Checkpoints: Implication
for Aging?
The Batf shRNAwasmost strongly selected in transplanted telo-
mere dysfunctional HSCs compared to wild-type HSCs, also
among other shRNAs in the iRNA library that targeted well known
DNA damage checkpoint genes (Table S4). These data indicate
that BATF represents a major pathway limiting HSC function in
response to DNA damage. It is conceivable that this newly
defined checkpoint affects aging of the hematopoietic systemietic Stem Cells
iesis and myelopoiesis-related genes (Table S3) in freshly isolated (A) HSCs
CD34-KSL) from 2 month old, nonirradiated versus irradiated mTerc+/+ mice (4
er transplantation of shRNA-Batf versus scrambled shRNA targeted KSL cells
as box blots in a log transformation so that a fold change of 1 is represented by
hange being equal to 1 (n = 2 pools of 4-6 mice per group).
BatfshRNAtransducedKSLcells from Il7R- reportermice.Engrafted recipients
group, values are shown as mean ± SD). 12 hr later, IL7R-reporter activity was
percentageof IL7R-reporter-positivecells inmyeloid competentHSCs (CD150hi)
7R-reporter induction:gates in left panel indicateKSLcells, gates inmiddlepanel
D150hi (upper gates) and CD150lo (lower gates) HSCs. (F) Representative FACS
pients thatwere transplantedwithBatfshRNAor scrambledshRNA infectedKSL
in Batf shRNA-infected HSCs (GFP+, upper gate in lower panel) compared to
7R-reporter activity in noninfected HSCs in both cohorts (GFP-).
hoid competent HSCs (CD150loCD34-LSK cells) were seeded on OP9 feeder
y) and in nonirradiated controls (n = 3 repeat experiments, values are shown as
50hiCD34-KSL cells, 24 hr after IR versus non-IR, (H) representative FACS blots
rsus non-IR, (I) The histogram shows the percentage of IL7R-positive cells in
as mean ± SEM, n = 3 mice per group.
Batf shRNA or scrambled shRNA infected KSL cells from IL7R-reporter mice.
nd g-irradiated with 4Gy (IR) or nonirradiated (NIR), followed by FACS analysis
e shown as mean ± SEM, n = 5mice per group. (K) Representative FACS blots.
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Figure 6. BATF-Dependent Differentiation Contributes to HSC Depletion in Response to g-Irradiation
(A) Histogram showing the absolute number of CD150hi and CD150lo HSCs in bone marrow of 2 month oldmTerc+/+mice at the indicated time points after 4 Gy
g-irradiation. Values are shown as mean ± SD, n = 3 mice per group for each time point.
(B–D) Mathematical modeling of the observed changes in cell number in response to irradiation: (C) Model without DNA damage-induced differentiation, solely
based on changes of cell numbers by cell death and proliferation (Figure S6A,B), (B) DNA damage-induced differentiation was included in the delay-differential
equations assuming that CD150hi HSCs differentiated into CD150lo HSCs and CD150lo HSCs were depleted from the stem cell pool by induction of lymphocyte
differentiation, (D) Box blot showing the mean error of cell numbers in mathematical models compared to the observed data.
(E–G) The histograms depict the number of CD150hi and CD150lo HSCs in: (E) irradiated (12 hr after IR) versus nonirradiated Batf/ and Batf+/+mice; (F) irradiated
(24h after IR) versus nonirradiated recipients of Batf shRNA or scrambled shRNA (control) infected KSL cells (4 months after transplantation); (G) irradiated (24 hr
after IR) versus nonirradiated G-Csf/ and G-Csf-+/ mice (n = 5 mice per group). (E–G) Values are shown as mean ± SEM, n = 4–5 mice per group.
See Extended Experimental Procedures and Figure S6 and Figure S7.since there is growing evidence for DNA damage accumulation
in aging HSCs (Rossi et al., 2007, Ru¨be et al., 2011).
Impaired replication potential and skewing in differentiation
represent the most prominent phenotypes of the aging
hematpoietic system. Studies on the cellular composition of
bone marrow-derived HSCs in mice revealed evidence that the
HSC pool consists of distinct subpopulations exhibiting a
different potential to undergo myeloid or lymphoid differentiation
(Challen et al., 2010). Aging associated skewing of hematopoi-
esis was recently associated with an increased survival of
myeloid competent HSCs in aging mice supporting a population
shift model of HSC aging (Cho et al., 2008, Beerman et al., 2010).
According to this model myeloid competent HSCs are selected
and outcompete lymphoid competent HSCs during aging. The
molecular mechanisms that control this selection process during
aging are unknown. The current study shows that BATF-depen-
dent differentiation limits the repopulation capacity and self-
renewal of HSCs in response to telomere dysfunction or g-irradi-
ation. Since lymphoid competent HSCs (CD150lo) were moresensitive to this checkpoint, it is possible that BATF upregulation
contributes to the ablation of lymphoid competent HSCs in
response to aging associated DNA damage accumulation.
In summary, the current study provides evidence for a G-CSF/
Stat3/BATF-dependent checkpoint, which limits self-renewal
of HSCs in response to DNA damage or telomere dysfunction
by induction of lymphoid differentiation. These data support a
new concept indicating that DNA damage limits self-renewal of
damaged stem cells by activating tissue specific differentiation
pathways. The newly discovered differentiation checkpoint
appears to be conserved in human HSCs and could impact on
age-associated changes in stem cell differentiation and transfor-
mation in the hematopoietic system.EXPERIMENTAL PROCEDURES
Mice
Mice were maintained in a pathogen-free environment and fed with a standard
diet. All mice were in a C57BL6J background. Animal experiments wereCell 148, 1001–1014, March 2, 2012 ª2012 Elsevier Inc. 1011
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Figure 7. DNADamage-Dependent Upregu-
lation of BATF in Hematopoietic Cells
Contributes to the Activation of Checkpoint
Genes and Is Maintained in Human CD34+
Hematopoietic Cells
(A and B) Histograms showing mRNA expression
of p21 (A) and p16 (B) relative to GAPDH in freshly
isolated HSCs (CD34-KSL) from 8-10 month old
mTerc+/+ and G3 mTerc/ mice, and from long-
term reconstituted mice, 16 weeks after trans-
plantation of hematopoietic cells from G3
mTerc/ that were transduced with a Batf shRNA
or a scrambled shRNA (n = 3 per group, values are
shown as mean ± SEM).
(C) Representative Western blot showing the
expression of phospho-p53 in freshly isolated Lin-
cells from bone marrow of long-term reconstituted
mice, 16 weeks after transplantation of shRNA-
Batf or scrambled shRNA transduced G3
mTerc/ hematopoietic cells (n = 3 mice per
group).
(D) Hematopoietic cells from mTerc+/+ mice were
transduced with shRNA-Batf or scrambled shRNA
and transplanted into lethally irradiated recipients.
Two months after transplantation one group of the
recipients was irradiated with 4 Gy g-irradiation.
Representative Western blot showing the expres-
sion of phospho-p53 in freshly isolated Lin- cells
from bone marrow of nonirradiated and irradiated
recipients (6 hr after IR, n = 3mice per group). Note
that shRNA knockdown of Batf impaired g-irradi-
ation induced p53 phosphorylation.
(E–G) Telomere length and the mRNA expression
of p16 and Batf (relative to Gapdh) was measured
in CD34+ human HSCs from patients with myelo-
dysplastic syndrome (MDS, n = 26): The histo-
grams show (E) the correlation between p21
mRNA level and telomere length, (F) p21 mRNA
level andBatfmRNA level, and (G) Batf mRNA level
and telomere length. Note that telomere short-
ening and the induction of p21 correlates with
induction of Batf in human CD34+ HSCs.approved by the state government of Baden-Wu¨rttemberg (Protocol Number
35/9185.81-3/919).
Plasmid and Lentiviral Vector Construction
SF-LV-shRNA-EGFP: the spleen-focus forming promoter (SFFV) driven GFP
expression cassette was inserted into the lentiviral GIPZ (Open Biosystems,
Huntsville, USA) vector. The IRES-puromycin cassette was replaced by the
120bp fragment harboring the 50mir30 sequence: 50mir30 50-AGCGGCCG
CAAATTCCGGTTTGTTTGAATGAGGCTTCAGTACTT-30 and 30mir30 50-TAC
CTCGACTCGAGCCTTCTGTT-30 to create the final vector SF-LV-shRNA-EGFP.
Lentivirus Production
Lentivirus was produced in 293T cells after transfection of 20mg shRNA plasmid,
15 mg pCMVDR8.91 helper plasmid and 6 mg pMD.G according to standard
procedures (Schambach et al., 2006). Virus was concentrated by centrifugation
at 25,000rpm for 2.5 hr, 4C, virus pellet was resuspended in sterile PBS.
cDNA Clone
Batf cDNA was amplified (forward primer: ACTGCTCGAGGCCACCATGCCT
CACAGCTCCG and reverse primer: CAGTGCGGCCGCAACTATCCACCCC
CTGC) and inserted into SF-LV-cDNA-EGFP.1012 Cell 148, 1001–1014, March 2, 2012 ª2012 Elsevier Inc.Western Blot
Whole-cell extracts were obtained in RIPA buffer and subjected to
15% SDS-PAGE using antibodies against BATF (1:1000, Abnova and
Abcam), phosphor-p53-Ser15 (1:1000, Cell Signaling) and beta-actin
(1:10000, Sigma).
For HSC analysis bone marrow was collected from five 12 month old
mice. Lin-cells were purified by MACS, followed by FACS purification of
3x104 CD34-KSL cells. Cells were lysed in loading buffer (50mM Tris base
pH6.8, 4% SDS, 0.04% Bromphenolblau, 20% glycerol) and the entire lysate
was loaded after boiling.
shRNA Recovery
Genomic DNA was isolated from lineage negative bone marrow cells (Gentra
Puregene Blood Kit, QIAGEN) and the integrated proviral sequences were
amplified with primers flanking the mir30 cassette (for details see Zuber
et al., 2011).
RNA Isolation
Total RNA was isolated from freshly isolated and sorted HSCs by using
MagMAX 96 total RNA isolation Kit (Ambion) due to the manufactors
protocol.
Quantitative Real-Time PCR
Quantitative real-time PCR was performed with an ABI 7300 Real-Time PCR
System (Applied Biosystems) in duplicates from at least 3 biological samples.
The superscript III kit (Invitrogen) was used for cDNA synthesis from total RNA.
Table S4 depicts primer sets for the detection of single genes. The quantitative
PCR was carried out in a volume of 25ml using the iTaq SYBR Green supermix
with Rox (Bio-Rad).
Flow Cytometry
For flow cytometric analysis, and sorting, hind limb bones were dissected and
single-cell suspensions were stained with antibodies, as previously described
(Ema et al., 2006). Data acquisition and cell sorting were performed on FACS
LSRII and FACSAriaII (BD Biosciences). Data were analyzed with the FlowJo
software.
Statistics
SPSS 11.5 was used for statistical analyses. Unpaired Student’s t test and
Chi-Square Test was used to generate P values for most of the datasets.
Otherwise it is stated in the figure legends.
Mathematical Modeling
Delay-differential equations were used to model changes in cell numbers and
integrated numerically (Mathematica V8, Wolfram Research). Functions for
effects of proliferation and apoptosis were fitted to data from the experiments
(see Supplemental Experimental Methods, Figure 6A, Figure S6). Differentia-
tion was modeled as occurring within a specific time frame (100 runs with
random starting values, latin hypercube sampling). Measured cell numbers
were utilized resulting in 35 = 243 possible combinations of data points. We
fitted models including differentiation and simplified models without differenti-
ation to each combination (comparison via the Wilcoxon test).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures,
five tables, and seven figures and can be found with this article online at
doi:10.1016/j.cell.2012.01.040.
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